{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T01:10:06Z","timestamp":1780967406495,"version":"3.54.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000102","name":"Health Resources and Services Administration","doi-asserted-by":"publisher","award":["UD9RH33633"],"award-info":[{"award-number":["UD9RH33633"]}],"id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","ajpm-online.net","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Medicine"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.amepre.2024.12.003","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:49:48Z","timestamp":1733446188000},"page":"580-587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Decreasing Incident Opioid Use Disorder, Especially Adolescent and Young Adult"],"prefix":"10.1016","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2869-2443","authenticated-orcid":false,"given":"Valerie S.","family":"Harder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel H.","family":"Schafrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine E.","family":"Peasley-Miklus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea C.","family":"Villanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.amepre.2024.12.003_bib0001","first-page":"1573","article-title":"Trends in opioid analgesic abuse and mortality in the United States","volume":"372","author":"Dart","year":"2015","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.amepre.2024.12.003_bib0002","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.amepre.2015.02.020","article-title":"Trends in Opioid Analgesic-Prescribing Rates by Specialty, U.S., 2007-2012","volume":"49","author":"Levy","year":"2015","journal-title":"Am J Prev Med"},{"issue":"2","key":"10.1016\/j.amepre.2024.12.003_bib0003","doi-asserted-by":"crossref","first-page":"221.e21","DOI":"10.1016\/j.amjmed.2015.10.002","article-title":"Trends in opioid prescriptions among part D medicare recipients from 2007 to 2012","volume":"129","author":"Kuo","year":"2016","journal-title":"Am J Med."},{"issue":"10","key":"10.1016\/j.amepre.2024.12.003_bib0004","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1001\/jamapediatrics.2021.1832","article-title":"Temporal trends in opioid prescribing practices in children, adolescents, and younger adults in the US from 2006 to 2018","volume":"175","author":"Renny","year":"2021","journal-title":"JAMA Pediatr"},{"issue":"3","key":"10.1016\/j.amepre.2024.12.003_bib0005","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3233\/JRS-220040","article-title":"A comparison of opioid prescription trends in England and the United States from 2008 to 2020","volume":"34","author":"Moncrieff","year":"2023","journal-title":"Int J Risk Saf Med"},{"issue":"4","key":"10.1016\/j.amepre.2024.12.003_bib0006","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1097\/j.pain.0000000000002101","article-title":"Patterns of opioid analgesic use in the U.S., 2009 to 2018","volume":"162","author":"Woods","year":"2021","journal-title":"Pain"},{"issue":"26","key":"10.1016\/j.amepre.2024.12.003_bib0007","doi-asserted-by":"crossref","first-page":"697","DOI":"10.15585\/mmwr.mm6626a4","article-title":"Vital signs: changes in opioid prescribing in the United States, 2006-2015","volume":"66","author":"Guy","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"12","key":"10.1016\/j.amepre.2024.12.003_bib0008","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/jamapediatrics.2022.3312","article-title":"Trends in dispensing of controlled medications for US adolescents and young adults, 2008 to 2019","volume":"176","author":"Toce","year":"2022","journal-title":"JAMA Pediatr"},{"issue":"13","key":"10.1016\/j.amepre.2024.12.003_bib0009","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJMra1507771","article-title":"Opioid abuse in chronic pain\u2013misconceptions and mitigation strategies","volume":"374","author":"Volkow","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amepre.2024.12.003_bib0010","unstructured":"Center for Public Health Law Research. Prescription Drug Abuse Policy System, State Laws Limiting Prescriptions for Opioid Analgesics. Accessed October 7, 2024, https:\/\/pdaps.org\/datasets\/opioid-analgesics-prescribing-limits"},{"key":"10.1016\/j.amepre.2024.12.003_bib0011","unstructured":"Vermont Department of Health. Rule Governing the Prescribing of Opioids for Pain. Accessed October 7, 2024, https:\/\/www.healthvermont.gov\/sites\/default\/files\/documents\/pdf\/REG_opioids-prescribing-for-pain.pdf"},{"key":"10.1016\/j.amepre.2024.12.003_bib0012","unstructured":"Vermont Department of Health. Vermont Prescription Monitoring System Rule. Accessed October 7, 2024, https:\/\/www.healthvermont.gov\/sites\/default\/files\/document\/reg-vpms-prescription-monitoring.pdf"},{"issue":"6","key":"10.1016\/j.amepre.2024.12.003_bib0013","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/pds.5425","article-title":"Evaluating opioid analgesic prescribing limits: a narrative review","volume":"31","author":"Seitz","year":"2022","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"10.1016\/j.amepre.2024.12.003_bib0014","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2023.4731","article-title":"Opioid prescribing patterns after imposition of setting-specific limits on prescription duration","volume":"5","author":"Allen","year":"2024","journal-title":"JAMA Health Forum"},{"key":"10.1016\/j.amepre.2024.12.003_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109626","article-title":"State prescribing cap laws' association with opioid analgesic prescribing and opioid overdose","volume":"240","author":"Tormohlen","year":"2022","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"10.1016\/j.amepre.2024.12.003_bib0016","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/pm\/pny215","article-title":"Impact of policy interventions on postoperative opioid prescribing","volume":"20","author":"MacLean","year":"2019","journal-title":"Pain Med"},{"key":"10.1016\/j.amepre.2024.12.003_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103306","article-title":"Prescription opioid policies and associations with opioid overdose and related adverse effects","volume":"97","author":"Harder","year":"2021","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.amepre.2024.12.003_bib0018","unstructured":"Vermont Department of Health. The Impact of Vermont's Rule for the Prescribing of Opioids for Pain. Accessed October 7, 2024, https:\/\/www.healthvermont.gov\/sites\/default\/files\/document\/Pain_Rules_Eval_DraftFINAL.pdf"},{"key":"10.1016\/j.amepre.2024.12.003_bib0019","unstructured":"Vermont Department of Health. 2019 and 2020 Annual VPMS Report. Accessed October 7, 2024, https:\/\/www.healthvermont.gov\/sites\/default\/files\/documents\/pdf\/ADAP-VPMS-AnnualReport-2019-2020.pdf"},{"issue":"2","key":"10.1016\/j.amepre.2024.12.003_bib0020","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/1073110520935336","article-title":"An Effective intervention: limiting opioid prescribing as a means of reducing opioid analgesic misuse, and overdose deaths","volume":"48","author":"Fink","year":"2020","journal-title":"J Law Med Ethics"},{"key":"10.1016\/j.amepre.2024.12.003_bib0021","unstructured":"Key substance use and mental health indicators in the United States: Results from the 2019 National Survey on Drug Use and Health (2020). Accessed December 18, 2024, https:\/\/store.samhsa.gov\/product\/results-2019-national-survey-drug-use-and-health-nsduh-key-substance-use-and-mental-health."},{"issue":"14","key":"10.1016\/j.amepre.2024.12.003_bib0022","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1001\/jama.2015.11859","article-title":"Nonmedical Prescription Opioid Use and Use Disorders Among Adults Aged 18 Through 64 Years in the United States, 2003-2013","volume":"314","author":"Han","year":"2015","journal-title":"Jama"},{"key":"10.1016\/j.amepre.2024.12.003_bib0023","article-title":"What is the prevalence of and trend in opioid use disorder in the United States from 2010 to 2019? Using multiplier approaches to estimate prevalence for an unknown population size","volume":"3","author":"Keyes","year":"2022","journal-title":"Drug Alcohol Depend Rep"},{"issue":"31","key":"10.1016\/j.amepre.2024.12.003_bib0024","doi-asserted-by":"crossref","first-page":"845","DOI":"10.15585\/mmwr.mm6731a1","article-title":"Opioid use disorder documented at delivery hospitalization - United States, 1999-2014","volume":"67","author":"Haight","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"10.1016\/j.amepre.2024.12.003_bib0025","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.amepre.2021.01.010","article-title":"Trends in opioid use disorder among older adults: analyzing medicare data, 2013-2018","volume":"60","author":"Shoff","year":"2021","journal-title":"Am J Prev Med"},{"issue":"3","key":"10.1016\/j.amepre.2024.12.003_bib0026","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/add.14867","article-title":"Trends in opioid use disorder and overdose among opioid-naive individuals receiving an opioid prescription in Massachusetts from 2011 to 2014","volume":"115","author":"Burke","year":"2020","journal-title":"Addiction"},{"issue":"11","key":"10.1016\/j.amepre.2024.12.003_bib0027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002941","article-title":"Trends in prescription opioid use and dose trajectories before opioid use disorder or overdose in US adults from 2006 to 2016: A cross-sectional study","volume":"16","author":"Wei","year":"2019","journal-title":"PLoS Med"},{"issue":"10","key":"10.1016\/j.amepre.2024.12.003_bib0028","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.34671","article-title":"Opioid dose trajectories and associations with mortality, opioid use disorder, continued opioid therapy, and health plan disenrollment","volume":"5","author":"Binswanger","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.amepre.2024.12.003_bib0029","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA). Key substance use and mental health indicators in the Unites States: Results from the 2023 National Survey on Drug Use and Health. Accessed October 7, 2024, https:\/\/www.samhsa.gov\/data\/report\/2023-nsduh-annual-national-report"},{"issue":"11","key":"10.1016\/j.amepre.2024.12.003_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002922","article-title":"Prescription opioid use and misuse among adolescents and young adults in the United States: a national survey study","volume":"16","author":"Hudgins","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/j.amepre.2024.12.003_bib0031","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.drugalcdep.2017.10.013","article-title":"Nonmedical prescription opioids and pathways of drug involvement in the US: Generational differences","volume":"182","author":"Wall","year":"2018","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.amepre.2024.12.003_bib0032","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.drugpo.2013.10.004","article-title":"Every 'never' I ever said came true\": transitions from opioid pills to heroin injecting","volume":"25","author":"Mars","year":"2014","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.amepre.2024.12.003_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.109232","article-title":"The effect of state policies on rates of high-risk prescribing of an initial opioid analgesic","volume":"231","author":"Stein","year":"2022","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.amepre.2024.12.003_bib0034","unstructured":"Green Mountain Care Board. Data from: Vermont Health Care Uniform Reporting and Evaluation System - VHCURES. 2022;Extract ID 3004."},{"issue":"7","key":"10.1016\/j.amepre.2024.12.003_bib0035","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1001\/jamapediatrics.2019.6235","article-title":"Patterns of Mean Age at Drug Use Initiation Among Adolescents and Emerging Adults, 2004-2017","volume":"174","author":"Alcover","year":"2020","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.amepre.2024.12.003_bib0036","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders (5th ed). https:\/\/doi.org\/10.1176\/appi.books. 9780890425596"},{"key":"10.1016\/j.amepre.2024.12.003_bib0037","unstructured":"American Psychiatric Association. Changes to ICD-10-CM Codes for DSM-5 Diagnoses. Accessed October 7, 2024, https:\/\/www.psychiatry.org\/psychiatrists\/practice\/dsm\/updates-to-dsm\/coding-updates"},{"key":"10.1016\/j.amepre.2024.12.003_bib0038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/CLEP.S181242","article-title":"Measuring prevalence and incidence of chronic conditions in claims and electronic health record databases","volume":"11","author":"Rassen","year":"2019","journal-title":"Clin Epidemiol"},{"issue":"2","key":"10.1016\/j.amepre.2024.12.003_bib0039","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/002204260503500202","article-title":"The developmental context of substance use in emerging adulthood","volume":"35","author":"Arnett","year":"2005","journal-title":"J Drug Issues"},{"issue":"5","key":"10.1016\/j.amepre.2024.12.003_bib0040","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1037\/0003-066X.55.5.469","article-title":"Emerging adulthood. A theory of development from the late teens through the twenties","volume":"55","author":"Arnett","year":"2000","journal-title":"Am Psychol"},{"issue":"2","key":"10.1016\/j.amepre.2024.12.003_bib0041","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/0163278714521812","article-title":"Emerging Adulthood: Developmental Period Facilitative of the Addictions","volume":"37","author":"Sussman","year":"2014","journal-title":"Eval Health Prof"},{"key":"10.1016\/j.amepre.2024.12.003_bib0042","unstructured":"Health Resources and Services Administration. Defining Rural Population. Accessed January 19, 2024, https:\/\/www.hrsa.gov\/rural-health\/about-us\/what-is-rural"},{"key":"10.1016\/j.amepre.2024.12.003_bib0043","series-title":"Stata Statistical Software","year":"2021"},{"issue":"457","key":"10.1016\/j.amepre.2024.12.003_bib0044","first-page":"1","article-title":"Drug overdose deaths in the United States, 2001-2021","author":"Spencer","year":"2022","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.amepre.2024.12.003_bib0045","unstructured":"Vermont Department of Health. Opioid-Related Fatal Overdoses Among Vermonters. Accessed October 7, 2024, https:\/\/www.healthvermont.gov\/sites\/default\/files\/documents\/pdf\/ADAP-OpioidFatalOverdoseDataBrief-202l.pdf"},{"issue":"11","key":"10.1016\/j.amepre.2024.12.003_bib0046","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1001\/jamapediatrics.2020.2539","article-title":"Association of opioid prescription initiation during adolescence and young adulthood with subsequent substance-related Morbidity","volume":"174","author":"Quinn","year":"2020","journal-title":"JAMA Pediatr"},{"issue":"2","key":"10.1016\/j.amepre.2024.12.003_bib0047","doi-asserted-by":"crossref","first-page":"25","DOI":"10.15585\/mmwr.mm6802a1","article-title":"Opioid prescribing rates in nonmetropolitan and metropolitan counties among primary care providers using an electronic health record system - United States, 2014-2017","volume":"68","author":"Garc\u00eda","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"14","key":"10.1016\/j.amepre.2024.12.003_bib0048","first-page":"377","article-title":"Poisoning deaths involving opioid analgesics - New York State, 2003-2012","volume":"64","author":"Sharp","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.amepre.2024.12.003_bib0049","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.addbeh.2018.05.030","article-title":"Increased use of heroin as an initiating opioid of abuse: further considerations and policy implications","volume":"87","author":"Cicero","year":"2018","journal-title":"Addict Behav"},{"issue":"1","key":"10.1016\/j.amepre.2024.12.003_bib0050","first-page":"12","article-title":"Causation and common liability in the progression of the U.S. Opioid crisis","volume":"85","author":"Dash","year":"2024","journal-title":"J Stud Alcohol Drugs"},{"key":"10.1016\/j.amepre.2024.12.003_bib0051","unstructured":"Kaiser Family Foundation. State Health Facts. Health Insurance Coverage of the Total Population. Data Source: U.S. Census Bureau. 2008-2022 American Community Survey, 1-Year Estimates. Accessed October 7, 2024, https:\/\/www.kff.org\/statedata\/ and https:\/\/www.census.gov\/programs-surveys\/acs\/"},{"key":"10.1016\/j.amepre.2024.12.003_bib0052","unstructured":"U.S. Census Bureau. Race Data. Accessed October 9, 2024, https:\/\/www.census.gov\/topics\/population\/race\/data.html"}],"container-title":["American Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379724004197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379724004197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T18:08:30Z","timestamp":1740420510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749379724004197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0749379724004197"],"URL":"https:\/\/doi.org\/10.1016\/j.amepre.2024.12.003","relation":{},"ISSN":["0749-3797"],"issn-type":[{"value":"0749-3797","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decreasing Incident Opioid Use Disorder, Especially Adolescent and Young Adult","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amepre.2024.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}